Saint Martin (French Part) vs United States Virgin Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Saint Martin (French Part)
0.2%
in 2024
United States Virgin Islands
0.2%
in 2024
Saint Martin (French Part) rank
98th
United States Virgin Islands rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Saint Martin (French Part)
- United States Virgin Islands
How they compare
Saint Martin (French Part) currently reports 0.2% against 0.2% in United States Virgin Islands, a difference of 0.0%.
Across all 10 years both countries report, United States Virgin Islands has been ahead every year.
Saint Martin (French Part) ranks 98th and United States Virgin Islands ranks 98th of 246 countries.
Head to head by decade
| Decade | Saint Martin (French Part) | United States Virgin Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Saint Martin (French Part) or United States Virgin Islands?
- Saint Martin (French Part), at 0.2% against 0.2% in United States Virgin Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Saint Martin (French Part) and United States Virgin Islands?
- 0.0%, with Saint Martin (French Part) ahead.
- How many years of comparable data are there for Saint Martin (French Part) and United States Virgin Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Saint Martin (French Part) and United States Virgin Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Saint Martin (French Part) ranks 98th and United States Virgin Islands ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.